ESMO - Oral presentation

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    Noxopharm will make an oral presentation at ESMO ASIA on 18 November, in which it will provide an update on the trial in Georgia. See: https://cslide.ctimeetingtech.com/asia2017/attendee/confcal/session/calendar?q=kelly

    The award of Late Breaking Abstract by ESMO, together with a speaking spot, suggests NOX will present efficacy data from the combination of chemotherapy and NOX66.  Under LBA rules, details of the abstract will not be released by ESMO before the actual presentation.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
8.9¢
Change
0.000(0.00%)
Mkt cap ! $26.00M
Open High Low Value Volume
8.9¢ 8.9¢ 8.9¢ $1.385K 15.56K

Buyers (Bids)

No. Vol. Price($)
1 52934 8.8¢
 

Sellers (Offers)

Price($) Vol. No.
9.3¢ 10239 1
View Market Depth
Last trade - 10.17am 17/09/2025 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.